Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer

Translational Lung Cancer Research

Volumn 2, Issue 1, 2013, Pages E17-E22

  Zarogoulidis, Paul ^a,b   Darwiche, Kaid ^b   Kalamaras, George ^a   Huang, Haidong ^c   Hohenforst Schmidt, Wolfgang ^d   Zarogoulidis, Konstantinos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b RUHRLANDKLINIK   (Germany)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cancer; Chrono modulation; Non small cell lung cancer (NSCLC)

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CHRONO TARGETED CHEMOTHERAPY; CIRCADIAN RHYTHM; COMPARATIVE STUDY; NEBULIZATION; NON SMALL CELL LUNG CANCER; PERSONALIZED MEDICINE; SLEEP DISORDER; SLEEP DISORDER ASSESSMENT; TARGETED CHEMOTHERAPY;

EID: 84888266847     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2012.12.07     Document Type: Article

References (20)

1. Zarogoulidis P, Chatzaki E, Porpodis K, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine 2012;7:1551-72. Figure 1 Photo by George Kalamaras (a lung cancer patient receiving before chemotherapy treatment). Actiwatch spectrum (Philips, Respironics) purchased by "Athromed Company" for Paul Zarogoulidis
2. Zarogoulidis P, Eleftheriadou E, Sapardanis I, et al. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs 2012;30:1628-40.
3. Zarogoulidis P, Steiropoulos P, Perantoni E, et al. Subjective sleep quality in lung cancer patients before and after chemotherapy. Thoracic Cancer 2012. [Epud ahead of print].
4. Lévi F, Altinok A, Clairambault J, et al. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philos Transact A Math Phys Eng Sci 2008;366:3575-98.
5. Li XM, Delaunay F, Dulong S, et al. Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timing. Cancer Res 2010;70:3351-60.
6. Lévi F, Focan C, Karaboué A, et al. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv Drug Deliv Rev 2007;59:1015-35.
7. Miaskowski C, Lee K, Dunn L, et al. Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs 2011;34:255-68.
8. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
9. Craver LF. The nitrogen mustards; clinical use. Radiology 1948;50:486-93.
10. Lee KA. Self-reported sleep disturbances in employed women. Sleep 1992;15:493-8.
11. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991;36:291-8.
12. Cimprich B. Attentional fatigue following breast cancer surgery. Res Nurs Health 1992;15:199-207.
13. Tsara V, Serasli E, Amfilochiou A, et al. Greek version of the Epworth Sleepiness Scale. Sleep Breath 2004;8:91-5.
14. Katsarou Z, Bostantjopoulou S, Hatzizisi O, et al. Immune factors or depression? Fatigue correlates in Parkinson's disease. Rev Neurol 2007;45:725-8.
15. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008;58:226-7.
16. Leclerc J, Courcot-Ngoubo Ngangue E, Cauffiez C, et al. Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues. Biochimie 2011;93:1012-27.
17. Okyar A, Piccolo E, Ahowesso C, et al. Strain-and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum. PLoS One 2011;6:e20393.
18. Bouchahda M, Adam R, Giacchetti S, et al. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer. Cancer 2009;115:4990-9.
19. Innominato PF, Focan C, Gorlia T, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 2009;69:4700-7.
20. Sato S, Kigawa J, Irie T, et al. Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer. Am J Clin Oncol 2002;25:289-90.